Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Psychiatry Res ; 104(2): 119-31, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11711166

ABSTRACT

This paper describes the cognitive functioning of a community cohort of individuals presenting with a first episode of a schizophrenia spectrum psychosis. Data were obtained for 107 patients (mean age 25 years) following stabilization of acute psychotic symptoms, mostly with the use of novel antipsychotics, on measures of intellectual, memory, attentional and executive functioning using a standardized battery of cognitive measures, including WAIS III and WMS III. While patients generally performed in the average range across the majority of measures, deficits (Z-scores >1.0 S.D.) were observed on measures of speed of information processing (PASAT, WAIS III) and executive functions (Stroop Test and Trails B), with the greatest deficits observed on tests of processing speed (PASAT). Discrepancy scores between the NART and the WAIS suggest subtle but statistically significant declines in full scale and performance IQ following onset of psychosis. Differences in cognitive functioning between diagnostic groups were not supported. Comparison of the highest and lowest functioning patients with respect to the cognitive measures also did not support any demographic or clinical differences between these two subgroups. Our results suggest a relatively benign cognitive profile in first-episode schizophrenia spectrum psychosis, regardless of diagnosis, when most potential incidence cases in the community are included. The most severe deficits reported were on measures of speeded information processing, and level of performance did not distinguish between patients demographically or clinically.


Subject(s)
Neuropsychological Tests , Schizophrenia/diagnosis , Schizophrenic Psychology , Adolescent , Adult , Antipsychotic Agents/therapeutic use , Combined Modality Therapy , Female , Humans , Male , Patient Care Team , Schizophrenia/rehabilitation , Social Adjustment
2.
Can J Psychiatry ; 44(3): 245-52, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10225125

ABSTRACT

OBJECTIVE: To review the nature of cognitive-behavioural interventions for psychosis and to evaluate evidence of their effectiveness. METHOD: Electronic (Medline and Psychinfo) and bibliography-based searches were carried out to locate descriptions and evaluations of cognitive-behavioural interventions for psychosis. RESULTS: Various cognitive-behavioural interventions have been used for reducing psychosis. These have usually been applied to auditory hallucinations and/or delusions in otherwise treatment-resistant patients. Most evaluations comprise case studies or simple pre-post designs. Controlled trial evaluations are few, and although the results are promising, methodological problems limit the conclusions that can be drawn concerning the clinical utility of such approaches. CONCLUSIONS: More and better controlled trial evaluations of cognitive-behavioural interventions are needed in this area. If further research supports the efficacy of these techniques, issues related to clinical effectiveness, mediators of treatment effects, risks, and cost-effectiveness will also need to be addressed.


Subject(s)
Cognitive Behavioral Therapy/methods , Psychotic Disorders/therapy , Adaptation, Psychological , Clinical Trials as Topic , Cognitive Behavioral Therapy/standards , Humans , Psychotic Disorders/psychology , Treatment Outcome
3.
Clin Exp Immunol ; 94(1): 201-7, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8403507

ABSTRACT

The T cell receptor (TCR) V beta repertoire in peripheral blood lymphocytes (PBL) of a large number of healthy individuals was analysed by quantifying V beta-specific mRNA using the method of anchored multiprimer DNA amplification and a reverse dot blot assay. Among 16 V beta gene families examined, particular V beta genes were noted to be unequally expressed in the PBL of 70 healthy donors. The frequently used genes belong to the V beta 4, 5, 6, 8 and 13 (12) families, while V beta 1, 9 and 15 were the least frequently used gene families. This bias in gene usage was observed in all individuals. Marked deviation from the mean percentage usage was noted for some V beta genes in individuals when their PBL were examined serially, but the common pattern of biased usage was not grossly distorted. When the TCR repertoire of different ethnic groups was examined, a lower mean frequency of V beta 3.2 was seen in the repertoire of 19 Caucasians compared with 25 age-matched Samoans (P < 0.003). Conversely, the expression of V beta 5.1 and V beta 5.3 was higher in Caucasians than in 51 age-matched Polynesians (Maoris and Samoans, P < 0.003). Considering the 20% co-efficient of variation in the estimate of V beta gene usage, our data from 70 unrelated individuals suggest that in PBL, individual variations in the TCR repertoire were superimposed upon a common biased usage of V beta genes in the general population.


Subject(s)
Lymphocytes/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Base Sequence , Flow Cytometry , Genetics, Population , Humans , Molecular Sequence Data , Polynesia , White People
SELECTION OF CITATIONS
SEARCH DETAIL
...